Loading
Latest filing published 19 Jun 2016 for Zenith Epigenetics Corp., €3,120.
No signal scores available.
This profile gathers the share dealings of Kelly Bret McNeill in Zenith Epigenetics Corp. We count 3 filings; the first trade dates from 29 January 2016 and the latest from 14 June 2016.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 19 June 2016 came the latest disclosure, an option exercise for €3,120 in Zenith Epigenetics Corp. Typically, a trade is published a median of 5 days after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations